1374
J. Tamura et al. / Bioorg. Med. Chem. Lett. 22 (2012) 1371–1374
3. Kawashima, H. Biol. Pharm. Bull. 2006, 29, 2343.
As shown in Scheme 3, the imidate (25)8 having azide was ste-
4. Uyama, T.; Ishida, M.; Izumikawa, T.; Trybala, E.; Tufaro, F.; Bergström, T.;
Sugahara, K.; Kitagawa, H. J. Biol. Chem. 2006, 281, 38668.
5. Sugahara, K. N.; Hirata, T.; Tanaka, T.; Ogino, S.; Takeda, M.; Terasawa, H.;
Shimada, I.; Tamura, J.; ten Dam, G. B.; van Kuppevelt, T. H.; Miyasaka, M.
Cancer Res. 2008, 68, 7191.
6. Yamamoto, H.; Muramatsu, H.; Nakanishi, T.; Natori, Y.; Sakuma, S.; Ishiguro,
N.; Muramatsu, T. Biolchem. Biophys. Res. Commn. 2006, 351, 915.
7. Tamura, J.; Neumann, K. W.; Kurono, S.; Ogawa, T. Carbohydr. Res. 1998, 305, 43.
8. Tamura, J.; Tokuyoshi, M. Biosci. Biotech. Biochem. 2004, 68, 2436.
9. Tamura, J.; Nakada, Y.; Taniguchi, K.; Yamane, M. Carbohydr. Res. 2008, 343,
39.
10. Vibert, A.; Lopin-Bon, C.; Jacquinet, J.-C. Chem. Eur. J. 2009, 15, 9561.
11. Vibert, A.; Lopin-Bon, C.; Jacquinet, J.-C. Eur. J. Org. Chem. 2011, 4183.
12. Sherman, A. A.; Mironov, Y. V.; Yudina, O. N.; Nifantiev, N. E. Carbohydr. Res.
2003, 338, 697.
reoselectively coupled with HO(CH2)2NHZ in the same manner as
for the synthesis of 6 to give 27 in 50% yield. The levulinoyl group
of 27 was removed in 84% yield and the other imidate (26) was
coupled in the same manner as above to afford the tetrasaccharide
(29) in 43% yield. Two benzyliden acetals of 29 were removed to
obtain 30 and the primary alcohols of which were pivaloylated
to give 31 in a quantitative yield (2 steps). The two liberated hy-
droxyl groups were sulfated with SO3ꢁNMe3 in DMF to give 32 in
92% yield. All the acyl groups were quantitatively removed by
saponification to obtain 33.
We then examined the chemoselective reduction of the azide of
33 in the presence of Z. Z is thought to usually resist hydrogenoly-
sis in the presence of a Lindlar catalyst,14 but was completely re-
moved in our case. It seems that this reaction deeply depends on
the lot of the reagent or degree of Pd by PbSO4. An alternative Pd
catalyst, Pd–C/Ph2S,15 afforded the same result. We also tried the
reduction of azide with AcSH, but obtained a very low yield. Naka-
hara’s group achieved the reduction of azide with Zn and AcOH in
ethyl acetate.16 We employed Zn in AcOH but this afforded a
complicated reaction mixture. However, aq AcOH (AcOH:
H2O = 5:1) instead of glacial AcOH completely improved the reac-
tion to give 34 in 62% yield after N-acetylation. The final removal
of Z by hydrogenolysis and subsequent biotinylation at the non-
reducing end as above afforded CS-AA (3) in 58% yield (2 steps).
We confirmed the structures of 1–3 by 1H NMR spectroscopy and
TOF-MS.17
The tetrasaccharides having a biotin linker were immobilized
on plates and their affinity for midkine was investigated.18 We also
prepared a CS-AE type substrate, GlcAb-GalNAc(4S)b-GlcAb-Gal-
NAc(4S6S)b, by digestion with 6-O-sulfatase. Midkine exhibited
interaction with these tetrasaccharides. The KD values are summa-
rized in Table 1. Midkine had the highest affinity for CS-EE among
the tetraosyl biotins with other types of sulfation patterns. The KD
value of CS-AE is larger than that of CS-EE. It seems that the 6-O-
sulfate at the non-reducing terminal is important for binding to
midkine. The sulfate at the 4-position at the non-reducing end is
also involved in the interaction with midkine.
In summary, we synthesized chondroitin sulfate tetrasaccha-
rides having different sulfation patterns via the 2+2 coupling of
disaccharide units. These oligosaccharides are linked to biotin via
a hydrophilic linker. We clarified that midkine preferred the highly
sulfated EE-type sequence to the AE, AA and OO-type chondroitin
tetrasaccharides.
13. Rosen, T.; Lico, I. M.; Chu, D. T. W. J. Org. Chem. 1988, 53, 1580.
14. Wuts, P. G. M.; Green, T. W. Green’s Protective Groups in Organic Synthesis; John
Wiely & Sons: Weinheim, 2007.
15. Mori, A.; Mizusaki, T.; Kawase, M.; Maegawa, T.; Monguchi, Y.; Takao, S.;
Takagi, Y.; Sajiki, H. Adv. Synth. Catal. 2008, 350, 406.
16. Ueki, A.; Nakahara, Yu.; Hojo, H.; Nakahara, Yo. Tetrahedron 2007, 63, 2170.
17. 1H NMR assignments were confirmed by two-dimensional HH COSY
experiments using BRUKER ADVANCE II 600 MHz spectrometers with tert-
BuOH as an internal standard (1.23 ppm) in D2O. As an example of signal
assignments, 1III stands for a proton at C-1 of sugar residue III. Positions of the
protons in the aglycon are depicted in Scheme 1. Compound 1: 1H NMR: d 4.60
(dd, 1H, Jb,c = 7.86 Hz, Jc,d = 5.04 Hz, H-c), 4.51 (br d, 2H, J = 7.98 Hz, H-1I
,
or III
1IV), 4.50 (br d, 1H, J = 6.67 Hz, H-1III or I), 4.45 (d, 1H, J1,2 = 8.40 Hz, H-1II), 4.41
(dd, 1H, Jb,e = 4.56 Hz, H-b), 4.09 (d, 1H, J3,4 = 3.00 Hz, H-4IV), 3.98 (dd, 1H,
J1,2 = 8.52 Hz, J2,3 = 10.74 Hz, H-2IV), 3.93 (m, 1H, H-r), 3,91 (d, 1H, J3,4 = 3.12 Hz,
H-4II), 3.88 (d, 1H, J4,5 = 9.79 Hz, H-5I), 3.86 (dd, 1H, J2,3 = 10.80 Hz, H-2II), 3.83–
3.65 (m, 7H, H-4I, III, 5 III, 6II, IVx4), 3.80 (m, 1H, H-3IV), 3.76 (m, 5H, H-n, r), 3.68
(m, 2H, H-3II, 5IV), 3.68 (br s, 12H, H-m), 3.64–3.57 (m, 4H, H-3I, III, l ꢂ 2), 3.43
(m, 4H, H-k, q), 3.36 (m, 2H, H-2I, III), 3.32 (m, 1H, H-e), 2.98 (dd, 1H,
Jgem = 13.02 Hz, H-d), 2.77 (d, 1H, H-d0), 2.52 (br t, 2H, J = 6.09 Hz, H-o), 2.26 (br
t, 2H, J = 7.30 Hz, H-i), 2.02, 1.99 (2s, 3H ꢂ 2, 2NAc), 1.70 (m, 1H, H-f), 1.64 (m,
2H, H-h), 1.58 (m, 1H, H-f0), 1.40 (m, 2H, H-g).MALDI-TOFMS: m/z calcd for
C
51H84N6O30SNa, 1315.49; found, 1315.49 [M+Na+].Compound 2: 1H NMR: d
4.74 (s, 1H, H-4II), 4.67 (d, 1H, J3,4 = 2.28 Hz, H-4IV), 4.59 (m, 2H, H-1II, c), 4.54
(d, 1H, J1,2 = 9.78 Hz, H-1IV), 4.52 (d, 1H, J1,2 = 9.72 Hz, H-1I III), 4.52 (d, 1H,
or
J1,2 = 7.74 Hz, H-1III or I), 4.42 (dd, 1H, Jb,c = 7.87 Hz, Jb,e = 4.50 Hz, H-b), 4.02 (d,
1H, J = 9.78 Hz, H-5I), 4.01 (brd, 1H, J = 3.90 Hz, H-2II), 3.95 (d, 1H, J4,5 = 9.86 Hz,
H-5 III), 3.92 (m, 1H, H-r), 3.88 (dd, 1H, J2,3 = 12.43 Hz, H-2IV), 3.86 (m, 1H, H-
3IV), 3.84–3.65 (m, 6H, H-5II, IV, 6II, IV ꢂ 2), 3.82 (m, 2H, H-4I, III), 3.81 (m, 1H, H-
3II), 3.77 (m, 3H, H-n, r), 3.67 (m, 14H, H-3I, III, m), 3.62 (m, 2H, H-l), 3.42 (m,
4H, H-k, q), 3.38 (m, 2H, H-2I, III), 3.33 (m, 1H, H-e), 2.99 (dd, 1H,
Jgem = 13.08 Hz, Jc,d = 4.98 Hz, H-d), 2.77 (d, 1H, H-d0), 2.52 (t, 2H, J = 6.15 Hz,
H-o), 2.27 (t, 2H, J = 7.32 Hz, H-i), 2.02, 2.00 (2s, 3H ꢂ 2, 2NAc), 1.72 (m, 1H, H-
f), 1.62 (m, 2H, H-h), 1.59 (m, 1H, H-f0), 1.41 (m, 2H, H-g). MALDI-TOFMS: m/z
calcd for C51H80N6O42S5Na5, 1723.19; found, 1723.24 [M+Na+]. Compound 3:
1H NMR: d 4.76 (m, 1H, H-4II), 4.71 (d, 1H, J3,4 = 2.10 Hz, H-4IV), 4.62 (m, 1H, H-
1II), 4.60 (m, 1H, H-c), 4.60 (d, 1H, J1,2 = 7.80 Hz, H-1IV), 4.55 (d, 1H,
or
or
J1,2 = 7.98 Hz, H-1I
III), 4.54 (d, 1H, J1,2 = 7.92 Hz, H-1III
I), 4.42 (dd, 1H,
Jb,c = 7.92 Hz, Jb,e = 4.50 Hz, H-b), 4.29–4.20 (m, 4H, H-6II, ꢂ 2), 4.11 (m, 2H,
IV
H-5II, IV), 4.03 (m, 2H, H-2II,3II), 4.02 (d, 1H, J = 9.66 Hz, H-5I), 3.97 (d, 1H,
J4,5 = 9.78 Hz, H-5 III), 3.92 (m, 1H, H-r), 3.88 (m, 2H, H-2IV, 3IV), 3.83 (m, 2H, H-
4I, III), 3.77 (m, 3H, H-n, r), 3.71–3.64 (m, 14H, H-3I,
, m), 3.62 (t, 2H,
III
J = 5.34 Hz, H-l), 3.42 (m, 4H, H-k, q), 3.39 (m, 2H, H-2I, III), 3.33 (m, 1H, H-e),
2.99 (dd, 1H, Jgem = 13.08 Hz, Jc,d = 4.98 Hz, H-d), 2.77 (d, 1H, H-d0), 2.52 (t, 2H,
J = 6.09 Hz, H-o), 2.27 (t, 2H, J = 7.30 Hz, H-i), 2.02, 2.00 (2s, 3H ꢂ 2, 2NAc), 1.72
(m, 1H, H-f), 1.64 (m, 2H, H-h), 1.57 (m, 1H, H-f0), 1.41 (m, 2H, H-g).
Acknowledgment
This study was supported in part by a Grant-in-aid for Scientific
Research on Innovative Areas 3301, MEXT, Japan.
18. Streptavidin-coated sensor chip (Sensor Chip SA)(GE Healthcare) was washed
with 1 M NaCl at a flow rate of 30 ll/min according to the manufacture’s
instructions. Biotinylated tetrasaccharides diluted in HBS-EP buffer (10
mMHEPES, 0.15 M NaCl, 3.4 mM EDTA, 0.005% surfactant P20, pH 7.4) were
perfused and allowed to interact with the surface of the sensor at a flow rate of
References and notes
30
midkine concentrations (90, 180, and 360 nM)at 30
applied to the sensor chip (30 l/min) for 2 min and left to dissociate for 3 min.
Surfaces were regenerated using 1 M NaCl. Data were analyzed by BIA
evaluation 3.0 software using a 1:1 Langmuir binding model.
l
l/min. Kinetic analyses were performed using a range of recombinant
ll/min. Midkine was
1. Wang, H.; Katagiri, Y.; McCann, T. E.; Unsworth, E.; Goldsmith, P.; Yu, Z.-X.; Fei,
T.; Santiago, L.; Mills, E. M.; Wang, Y.; Symes, A.; Geller, H. M. J. Cancer Sci. 2008,
121, 3083.
l
2. Mikami, T.; Yasunaga, D.; Kitagawa, H. J. Biol. Chem. 2009, 284, 4494.